Stephen L. Silvestro - 19 Dec 2023 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Commercial Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol
OPRX
Transactions as of
19 Dec 2023
Transactions value $
$0
Form type
4
Filing time
21 Feb 2024, 18:22:31 UTC
Previous filing
06 Oct 2023
Next filing
06 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Stock Option Award $0 +19,639 $0 19,639 19 Dec 2023 Common Stock 19,639 $12.73 Direct F1
transaction OPRX Restricted Stock Units Award $0 +19,639 $0 19,639 19 Dec 2023 Common Stock 19,639 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.